PuSH - Publikationsserver des Helmholtz Zentrums München

Lian, F.* ; Xing, X.* ; Yuan, G.* ; Schäfer, C.* ; Rauser, S. ; Walch, A.K. ; Röcken, C.* ; Ebeling, M.* ; Wright, M.B.* ; Schmid, R.M.* ; Ebert, M.P.* ; Burgermeister, E.*

Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage.

Biochem. J. 438, 315-323 (2011)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Bile acids from duodenogastric reflux promote inflammation and increase the risk for gastro-oesophageal cancers. FXR (farnesoid X receptor/NR1H4) is a transcription factor regulated by bile acids such as CDCA (chenodeoxycholic acid). FXR protects the liver and the intestinal tract against bile acid overload; however, a functional role for FXR in the stomach has not been described. We detected FXR expression in the normal human stomach and in GC (gastric cancer). FXR mRNA and protein were also present in the human GC cell lines MKN45 and SNU5, but not in the AGS cell line. Transfection of FXR into AGS cells protected against TNFα (tumour necrosis factor α)-induced cell damage. We identified K13 (keratin 13), an anti-apoptotic protein of desmosomes, as a novel CDCA-regulated FXR-target gene. FXR bound to a conserved regulatory element in the proximal human K13 promoter. Gastric expression of K13 mRNA was increased in an FXR-dependent manner by a chow diet enriched with 1% (w/w) CDCA and by indomethacin (35 mg/kg of body weight intraperitoneal) in C57BL/6 mice. FXR-deficient mice were more susceptible to indomethacin-induced gastric ulceration than their WT (wild-type) littermates. These results suggest that FXR increases the resistance of human and murine gastric epithelial cells to inflammation-mediated damage and may thus participate in the development of GC.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.016
1.278
18
36
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter bile acid; chenodeoxycholic acid (CDCA); farnesoid X receptor (FXR); keratin; gastric cancer; stomach
Sprache englisch
Veröffentlichungsjahr 2011
HGF-Berichtsjahr 2011
ISSN (print) / ISBN 0264-6021
e-ISSN 1470-8728
Quellenangaben Band: 438, Heft: 2, Seiten: 315-323 Artikelnummer: , Supplement: ,
Verlag Portland Press
Begutachtungsstatus Peer reviewed
POF Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30205 - Bioengineering and Digital Health
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-500300-001
G-500390-001
PubMed ID 21619550
Scopus ID 80051703916
Erfassungsdatum 2011-11-29